Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is E  [Clear All Filters]
2024
Valente DSouto, Ely PBins, Kieling L, Konzen ATerezinha, Steffen LPastori, Lazzaretti GSulczinski, Zanella RKoehler. Breast fat grafting and cancer: a systematic review of the science behind enhancements and concerns. Transl Breast Cancer Res. 2024;5:14.
Odak I, Bayir LM, Riemann L, Sikora R, Schneider J, Xiao Y, Möhn N, Skripuletz T, Beutel G, Eder M, et al. Brief research report: in-depth immunophenotyping reveals stability of CD19 CAR T-cells over time. Front Immunol. 2024;15:1298598.
Nobre TAlves, de Sousa AAlves, Pereira ICosta, Pedrosa-Santos ÁMara Carva, Lopes Lde Oliveir, Debia N, El-Nashar HAS, El-Shazly M, Islam MTorequl, Sousa JMarcelo de, et al. Bromelain as a natural anti-inflammatory drug: a systematic review. Nat Prod Res. 2024:1-14.
Nobre TAlves, de Sousa AAlves, Pereira ICosta, Pedrosa-Santos ÁMara Carva, Lopes Lde Oliveir, Debia N, El-Nashar HAS, El-Shazly M, Islam MTorequl, Sousa JMarcelo de, et al. Bromelain as a natural anti-inflammatory drug: a systematic review. Nat Prod Res. 2024:1-14.
Pradeepan KS, McCready FP, Wei W, Khaki M, Zhang W, Salter MW, Ellis J, Martinez-Trujillo J. Calcium-Dependent Hyperexcitability in Human Stem Cell-Derived Rett Syndrome Neuronal Networks. Biol Psychiatry Glob Open Sci. 2024;4(2):100290.
Majd H, Cesiulis A, Samuel RM, Richter MN, Elder N, Guyer RA, Hao MM, Stamp LA, Goldstein AM, Fattahi F. A call for a unified and multimodal definition of cellular identity in the enteric nervous system. bioRxiv. 2024.
Pallavi R, Gatti E, Durfort T, Stendardo M, Ravasio R, Leonardi T, Falvo P, Duso BAchutti, Punzi S, Xieraili A, et al. Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion. Nat Commun. 2024;15(1):828.
Chinnapaka S, Malekzadeh H, Tirmizi Z, Ejaz A. Caloric restriction mitigates age-associated senescence characteristics in subcutaneous adipose tissue-derived stem cells. Aging (Albany NY). 2024;16.
Teppert K, Ogusuku IElias Yone, Brandes C, Herbel V, Winter N, Werchau N, Khorkova S, Wöhle C, Jelveh N, Bisdorf K, et al. CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment. Mol Ther Oncol. 2024;32(2):200797.
Sato T, Oshi M, Huang JLi, Chida K, Roy AMariam, Endo I, Takabe K. CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer. Res Sq. 2024.
Bianchi M, Reichen C, Croset A, Fischer S, Eggenschwiler A, Grübler Y, Marpakwar R, Looser T, Spitzli P, Herzog C, et al. The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells. Cancer Immunol Res. 2024.
Caulier B, Joaquina S, Gelebart P, Dowling THelén, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NUmesh, Wogsland C, et al. CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia. Cell Rep Med. 2024:101572.
Ibneeva L, Singh SPal, Sinha A, Eski SElif, Wehner R, Rupp L, Kovtun I, Pérez-Valencia JAlberto, Gerbaulet A, Reinhardt S, et al. CD38 promotes hematopoietic stem cell dormancy. PLoS Biol. 2024;22(2):e3002517.
Herrera F, Torres D, Laborde A, Jordán R, Mañez N, Berruezo L, Lambert S, Suchowiercha N, Costantini P, Nenna A, et al. Ceftazidime-Avibactam Improves Outcomes in High-Risk Neutropenic Patients with Carbapenemase-Producing Enterobacterales Bacteremia. Microorganisms. 2024;12(1).
Kim DDong Hwan, Popradi G, Lepic K, Paulson K, Allan D, Nampoothiri RVasudevan, Lachance S, Deotare U, White J, Elemary M, et al. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development. Curr Oncol. 2024;31(3):1426-1444.
Krystel-Whittemore M, Petrova-Drus K, Ptashkin RN, Ewalt MD, Yao JJ, Liu Y, Zhu M, Benhamida J, Durham B, Kumar J, et al. Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies. Haematologica. 2024.
de Haan MJA, Jacobs ME, Witjas FMR, de Graaf AMA, Sánchez-López E, Kostidis S, Giera M, Novoa FCalderon, Chu T, Selzner M, et al. A cell-free nutrient-supplemented perfusate allows four-day ex vivo metabolic preservation of human kidneys. Nat Commun. 2024;15(1):3818.
Lindenhofer D, Haendeler S, Esk C, Littleboy JB, Avalos CBrunet, Naas J, Pflug FG, van de Ven EGP, Reumann D, Baffet AD, et al. Cerebral organoids display dynamic clonal growth and tunable tissue replenishment. Nat Cell Biol. 2024.
Lim RR, Shirali S, Rowlan J, Engel AL, Nazario M, Gonzalez K, Tong A, Neitz J, Neitz M, Chao JR. CFH Haploinsufficiency and Complement Alterations in Early-Onset Macular Degeneration. Invest Ophthalmol Vis Sci. 2024;65(4):43.
Rocha MS, Marques CF, Carvalho AC, Martins E, Ereskovsky A, Reis RL, Silva TH. The Characterization and Cytotoxic Evaluation of Collagen Isolated from Different Body Parts (Ectosome and Choanosome) Envisaging the Development of Biomaterials. Mar Drugs. 2024;22(2).
Bashore FM, Katis VL, Du Y, Sikdar A, Wang D, Bradshaw WJ, Rygiel KA, Leisner TM, Chalk R, Mishra S, et al. Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM. PLoS One. 2024;19(2):e0293548.
Sullivan MR, White RP, Kanetkar N, Fridman IBerger, Ekenseair A, Evens AM, Konry T. Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model. Cell Death Dis. 2024;15(1):18.
Sullivan MR, White RP, Kanetkar N, Fridman IBerger, Ekenseair A, Evens AM, Konry T. Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model. Cell Death Dis. 2024;15(1):18.
Lyssy F, Forstner D, Brugger BA, Ujčič K, Guettler J, Kupper N, Wernitznig S, Daxboeck C, Neuper L, El-Heliebi A, et al. The chicken chorioallantoic membrane assay revisited - A face-lifted approach for new perspectives in placenta research. Placenta. 2024.
Anon. [Chinese expert consensus on allogeneic hematopoietic stem cell transplantation for cerebral adrenoleukodystrophy (2023)]. Zhonghua Er Ke Za Zhi. 2024;62(4):303-309.

Pages